Merida Biosciences
Cambridge
About Merida Biosciences
Merida Biosciences is a new biotech company focused on developing precision treatments, particularly for autoimmune diseases. The company utilize a protein engineering platform to create unique Fc therapeutics, aiming to selectively bind to specific antibodies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $121.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2025)
- Website: meridabio.com
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/merida-biosciences-54836 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.